Lunit opens European unit to hasten expansion

Lunit opens European unit to hasten expansion

South Korean medical AI company Lunit has announced its decision to establish a wholly-owned subsidiary in Europe.According to a press release, Lunit Europe Holdings will be based in Amsterdam in the Netherlands and will begin local staff recruitment shortly. 
WHY IT MATTERS
Although Lunit had a branch office which previously managed its European business, its subsidiary in the continent will allow it to plan for the expansion of its sales network and fortify existing partnerships there. 
According to data from Statista, the European medical device market is expected to be worth $136 billion this year. Its biggest segment is cardiology devices with a projected…

Continue Reading
Morning Headlines 2/20/23

Morning Headlines 2/20/23

February 19, 2023 Headlines No Comments Reported HIPAA complaints and breaches shot up from 2017 to 2021: HHS
HHS OCR reports that it does not have the financial resources it needs to investigate mounting HIPAA breaches and complaints, both of which increased between 2017 and 2021.
Tallahassee Memorial HealthCare resumes normal operations, but questions loom
Tallahassee Memorial HealthCare (FL) announces that it has fully restored its computer systems and services 13 days after an unspecified security incident forced it to downtime procedures.
Lightbeam Health Solutions Is Relocating Its HQ from Las Colinas to Cypress Waters in Coppell
Population health management company Lightbeam Health Solutions…

Continue Reading
Monday Morning Update 2/20/23

Monday Morning Update 2/20/23

Top News

The VA postpones its planned July 2023 Oracle Cerner go-live at its Ann Arbor, MI facilities until later this year or early in 2024.
The service region is concerned about “how well EHRM would interact with VA Ann Arbor’s vital medical research mission.”

Reader Comments From AT: “Re: pet peeves with service industry words and phrases. ‘I appreciate you,’ following my thanking you and leaving you a tip, which suggests that we are like-minded, decent people even though you have no way of knowing that. Second is thanking someone with ‘of course,” implying that I’m either too stupid to know…

Continue Reading
Bonus Features – February 19, 2023 – 80% of orgs collect SDOH data but struggle to make use of it, 2 in 3 cybersecurity pros say their orgs underestimate threats, and more

Bonus Features – February 19, 2023 – 80% of orgs collect SDOH data but struggle to make use of it, 2 in 3 cybersecurity pros say their orgs underestimate threats, and more

Welcome to the weekly edition of Healthcare IT Today Bonus Features. This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Because there’s so much happening out there in healthcare IT we aren’t able to cover in our full articles, we still want to make sure you’re informed of all the latest news, announcements, and stories happening to help you better do your job.
Surveys
A survey of 2,600 AHIMA members found that about 80% of healthcare organizations are collecting social determinants of health data. The bad news: Organizations face multiple challenges…

Continue Reading
Weekly Roundup – February 18, 2023

Weekly Roundup – February 18, 2023

Welcome to our Healthcare IT Today Weekly Roundup. Each week, we’ll be providing a look back at the articles we posted and why they’re important to the healthcare IT community. We hope this gives you a chance to catch up on anything you may have missed during the week.
6 Organizations Approved As Initial QHINs Under TEFCA. CommonWell, eHealth Exchange, Epic, Health Gorilla, Kno2, and KONZA were named the inaugural QHINs. The announcement wasn’t much of a surprise, but John said it will be interesting to see which technology vendors ultimately get behind which QHINs. Read more…
Exploring LG’s Partnership With Amwell. LG…

Continue Reading
What Will Value-Based Drug Pricing Look Like By 2030? Experts Share 4 Predictions

What Will Value-Based Drug Pricing Look Like By 2030? Experts Share 4 Predictions

Editor’s note: This story is based on discussions at Abarca Forward, a conference in San Juan, Puerto Rico, hosted by Abarca, a pharmacy benefit manager. MedCity News’ Editor-in-Chief Arundhati Parmar and Senior Reporter Katie Adams were invited to attend and speak at the conference. All travel and related expenses for the team were covered by Abarca. However, company officials had no input in editorial coverage. 
The U.S. healthcare systems spent a whopping $301 billion on specialty drugs in 2021, a 43% increase since 2016. These specialty drugs accounted for half of the year’s total drug spending, and the list prices for specialty…

Continue Reading
Apellis Drug Becomes First Approved Therapy for Vision-Loss Disorder Geographic Atrophy

Apellis Drug Becomes First Approved Therapy for Vision-Loss Disorder Geographic Atrophy

Geographic atrophy, an eye disorder that starts as a loss of central vision and progressively worsens to total blindness, now has its first treatment. The FDA on Friday approved an Apellis Pharmaceuticals drug that slows the progression of this disease, which affects more than 1 million people in the U.S.
Approval of the Apellis drug, pegcetacoplan, covers all patients with geographic atrophy, a broad label that reflects the representative patient population tested in pivotal studies, Chief Medical Officer Caroline Baumal said during a Friday evening conference call. The Waltham, Massachusetts-based company plans to launch the drug in March, marketing the product under…

Continue Reading